Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tibolone in high risk women after oophorectomy
NCT00165204Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Apr 2004
- Primary completion
- Mar 2006
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Surgical Menopause and osteoporosis comparing Tibolone with Placebo (2 arms). Primary endpoints: Bone mineral density at 1 year and Markers of bone turnover at 1 year. Started Apr 2004; status: completed.
02
Drugs
tibolone
03
Conditions
Surgical Menopauseosteoporosis
Beyond the preview
Go deeper on NCT00165204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165204.